These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 26105438)
1. PP116. Circulating PlGF can help predict preeclampsia and adverse outcome in patients with suspected preeclampsia or fetal growth restriction. Sibiude J; Dionne MD; Guibourdenche J; Le Ray C; Anselem O; Serreau R; Goffinet F; Tsatsaris V Pregnancy Hypertens; 2012 Jul; 2(3):302-3. PubMed ID: 26105438 [TBL] [Abstract][Full Text] [Related]
2. Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. Sibiude J; Guibourdenche J; Dionne MD; Le Ray C; Anselem O; Serreau R; Goffinet F; Tsatsaris V PLoS One; 2012; 7(11):e50208. PubMed ID: 23209675 [TBL] [Abstract][Full Text] [Related]
3. PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies. Rana S; Hacker M; Merport A; Salahuddin S; Verlohren S; Perschel F; Karumanchi SA Pregnancy Hypertens; 2012 Jul; 2(3):273-4. PubMed ID: 26105382 [TBL] [Abstract][Full Text] [Related]
4. PP052. Diagnosis of pre-eclampsia and prediction of time to delivery in women with suspected pre-eclampsia presenting before 36 weeks' gestation. Daubert C; Morfeld C; Schild R Pregnancy Hypertens; 2013 Apr; 3(2):85-6. PubMed ID: 26105907 [TBL] [Abstract][Full Text] [Related]
5. OS085. Decreased maternal circulating PLGF is a significant predictor of length of pregnancy in women with hypertensive disorders of pregnancy. Gullai N; Stenczer B; Molvarec A; Veresh Z; Nagy B; Rigo J Pregnancy Hypertens; 2012 Jul; 2(3):224. PubMed ID: 26105299 [TBL] [Abstract][Full Text] [Related]
6. PP056. Placental growth factor is a better predictor of preterm birth than uterine or umbilical artery doppler in hypertensive disorders of pregnancy. Stenczer B; Molvarec A; Gullai N; Veresh Z; Nagy B; Rigo J Pregnancy Hypertens; 2012 Jul; 2(3):272. PubMed ID: 26105379 [TBL] [Abstract][Full Text] [Related]
7. OS065. Placental growth factor as a diagnostic and prognostic test forplacental complications of pregnancy. Ris-Stalpers C; Lahsinoui HH; Boussata S; van der Post JA Pregnancy Hypertens; 2012 Jul; 2(3):212. PubMed ID: 26105279 [TBL] [Abstract][Full Text] [Related]
8. PP143. Relationship between mid-pregnancy placenta growth factor and hemodynamics in the mother, fetus, and uterus. Woelkers DA; Ghashghaei R; Klisser K; Archer T Pregnancy Hypertens; 2012 Jul; 2(3):317. PubMed ID: 26105464 [TBL] [Abstract][Full Text] [Related]
9. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. Moore AG; Young H; Keller JM; Ojo LR; Yan J; Simas TA; Maynard SE J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2651-7. PubMed ID: 22861812 [TBL] [Abstract][Full Text] [Related]
10. [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients]. Husse S; Gottschlich A; Schrey S; Stepan H; Hoffmann J Z Geburtshilfe Neonatol; 2014 Feb; 218(1):34-41. PubMed ID: 24595913 [TBL] [Abstract][Full Text] [Related]
11. Preeclampsia and fetal growth. Odegård RA; Vatten LJ; Nilsen ST; Salvesen KA; Austgulen R Obstet Gynecol; 2000 Dec; 96(6):950-5. PubMed ID: 11084184 [TBL] [Abstract][Full Text] [Related]
12. Rheological parameters in the umbilical cord blood in moderate and severe forms of preeclampsia. Csorba R; Yilmaz A; Tsikouras P; Wieg C; Teichmann A; von Tempelhoff GF Clin Hemorheol Microcirc; 2013 Jan; 55(4):391-401. PubMed ID: 24113499 [TBL] [Abstract][Full Text] [Related]
13. [Study on the relation between concentration of circulating non-host fetal DNA in pregnant women and pre-eclampsia]. Tao H; Wang XM; Ji XH Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):808-11. PubMed ID: 16412324 [TBL] [Abstract][Full Text] [Related]
14. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age. De Paco C; Kametas N; Rencoret G; Strobl I; Nicolaides KH Obstet Gynecol; 2008 Feb; 111(2 Pt 1):292-300. PubMed ID: 18238965 [TBL] [Abstract][Full Text] [Related]
15. PP178. Antenatal sFlt1 and PlGF levels at 20-28weeks of gestation for prediction of the occurrence of preeclampsia: A preliminary report. Jantarasaengaram S; Tansatit T; Samkhoompim N Pregnancy Hypertens; 2012 Jul; 2(3):337. PubMed ID: 26105499 [TBL] [Abstract][Full Text] [Related]
16. OS087. Maternal characteristics, mean arterial pressure and PLGF in early prediction of preeclampsia. Kuc S; Koster MP; Franx A; Schielen PC; Visser GH Pregnancy Hypertens; 2012 Jul; 2(3):225-6. PubMed ID: 26105301 [TBL] [Abstract][Full Text] [Related]
17. PP051. Prediction of preeclampsia with the sFlt-1/PLGF ratio: impact of the slope of repeated measurements. Schoofs K; Engels T; Pape J; Henrich W; Stepan H; Verlohren S Pregnancy Hypertens; 2012 Jul; 2(3):269. PubMed ID: 26105374 [TBL] [Abstract][Full Text] [Related]
18. PP117. Measurement of sFlt-1 and PlGF for prediction of pregnancy associated diseases. Stubert J; Ullmann S; Bolz M; Bohlmann M; Külz T; Gerber B; Reimer T Pregnancy Hypertens; 2012 Jul; 2(3):303. PubMed ID: 26105439 [TBL] [Abstract][Full Text] [Related]
19. A single rapid point-of-care placental growth factor determination as an aid in the diagnosis of preeclampsia. Knudsen UB; Kronborg CS; von Dadelszen P; Kupfer K; Lee SW; Vittinghus E; Allen JG; Redman CW Pregnancy Hypertens; 2012 Jan; 2(1):8-15. PubMed ID: 26104984 [TBL] [Abstract][Full Text] [Related]
20. A Prospective Study of Placental Growth Factor Assay as a Novel Biomarker in Predicting Early-Onset Preeclampsia in High-Risk Patients. Mathur P; Mathur P; Maru L; Dave A J Obstet Gynaecol India; 2016 Oct; 66(Suppl 1):98-103. PubMed ID: 27651586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]